News

Today’s Top Stories In Diabetes News!

Telemedicine ups diabetic retinopathy screening

Telescreening for diabetic retinopathy (DR) in primary care clinics increased screening rates from approximately 25% to 40% in rural and underserved patients, researchers reported.
Of 1,661 patients screened during the 3-year study period, 80% had no DR, 11% had mild to moderate non-proliferative DR, and 9% had severe or proliferative DR that required treatment, said Seema Garg, MD, PhD, of the University of North Carolina at Chapel Hill, and colleagues.  (read more)

Advertisements

UT Austin researchers seek to prevent diabetes in at-risk population

Researchers at The University of Texas at Austin and The University of Texas Health Science Center at Houston (UTHealth) School of Public Health have received a $2.9 million, five-year award from the National Institute of Diabetes and Digestive and Kidney Diseases to prevent diabetes in Hispanics who are at risk of developing the disease, officials said Tuesday.

For more than 25 years, Sharon Brown, a professor at the UT Austin School of Nursing, in collaboration with Craig Hanis at the Human Genetics Center at UTHealth School of Public Health, has led the Starr County Border Health Initiative, a series of research studies conducted in an impoverished Texas-Mexico border community, university officials explained. During this time, she has developed and tested culturally tailored, community-based methods designed to help Mexican Americans take control of their diabetes and improve their health. (read more)

Success of stem cell therapy for diabetes depends on pre-transplant immune condition

An innovative method for treating type 1 diabetes based on the transplantation of hematopoietic stem cells taken from the patient’s own bone marrow began undergoing testing in Brazil 13 years ago. The results were highly variable. While some of the volunteers were able to stop self-injecting insulin for more than a decade, others had to resume use of the medication only a few months after receiving the experimental treatment. (read more)